Position in REGN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,870
-$447 QoQ
Shares Held
3
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,296
of 1,322 holders
Holding Since
Dec 2022
15 quarters on record
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Granite FO LLC holds $5,843 across 2 Biotechnology names. REGN ranks #2 (32.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8 | $3,973 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
3 | $1,870 |
All Filings in REGN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,870 | 3 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $2,317 | 3 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,315 | 3 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,686 | 3 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,575 | 3 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,902 | 3 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,136 | 3 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $896,707 | 853 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $893,375 | 850 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $821,003 | 853 | Shares | Sole | 2024-09-05 | |
| 2023-12-31 | $746,546 | 850 | Shares | Sole | 2024-09-05 | |
| 2023-09-30 | $699,516 | 850 | Shares | Sole | 2024-09-05 | |
| 2023-06-30 | $610,759 | 850 | Shares | Sole | 2024-09-05 | |
| 2023-03-31 | $821,670 | 1,000 | Shares | Sole | 2024-09-05 | |
| 2022-12-31 | $1,038,945 | 1,440 | Shares | Sole | 2024-09-05 | |
| No filing history on record for this holder in this stock. | ||||||